Facebook Twitter LinkedIn Google Plus RSS

ADMA Biologics Inc. closes $26.5M IPO

By ,

Ramsey-based ADMA Biologics Inc. announced Tuesday the closing of its previously announced initial public offering of 3.35 million shares of its common stock at a public offering price of $8.50 per share.

According to the announcement, aggregate net proceeds to ADMA, after deducting underwriting discounts and commissions, will be approximately $26.5 million. Oppenheimer & Co. acted as sole book-running manager for the offering, first priced last week. Ladenburg Thalmann & Co. Inc., Maxim Group LLC and Laidlaw & Co. Ltd. acted as co-managers.


Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy


Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!